Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

Enrollment is complete for the randomized part of ENHANCE, a Phase 3 trial testing a new dosing schedule for Briumvi in ...

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

Neuropsychiatric disorders need new drugs that offer improvement in safety and efficacy over currently available medicines. Draig Therapeutics has emerged from stealth with $140 million to support mid ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

Rheumatoid arthritis is a painful, progressive joint disease characterized by particularly acute flare-ups. Biologics, used to treat autoimmune diseases such as rheumatoid arthritis, target symptom ...

A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...

As launches grow more complex, softgels can help developers overcome challenges during early clinical development.

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

NeoGenomics reaffirmed its full-year 2025 guidance, projecting revenue between $720 million and $726 million, representing 9-10% growth from fiscal 2024. The company expects a net loss between $108 ...